A recent study demonstrated that levels of GPX4 and xCT are higher in MM plasma cells than their healthy counterparts, suggesting MM plasma cells may be utilising this antioxidant pathway to withstand elevations in ROS levels [56]. This evidence concerns the gene SLC7A11 and Miyoshi myopathy.